Skip to main content
Equibles

Eric Foster

Ardelyx, Inc. (ARDX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Ardelyx, Inc. publishes a filing, an earnings call transcript or a press release.

Get ARDX alerts

About Eric Foster

Eric Foster has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Ardelyx, Inc. on August 6, 2026. Ardelyx, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ardelyx, Inc. includes Michael Raab (CEO and Board Member), Keith Santorelli (CFO), Susan Hohenleitner (CFO) and 7 others.

Eric Foster on recent calls

“Ipserella revenue grew 33% year over year, and as Mike noted, we experienced significant payer hurdles that had a direct impact on access to Ipserella.”
Other, Ardelyx Q2 2026 Earnings ·
“So the IBSC market is a very large market. So in 2025, around 7,000 prescriptions in the market. You know, we focus on 14,000 HCP prescribers that represent about 50% of that total TRX market.”
Other, Jefferies Global Healthcare Conference in New York ·
“It was marked with incredible commercial execution and performance. We grew up as well by more than 70% versus the prior year, with record highs across all key performance metrics.”
Other, Ardelyx, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Ardelyx, Inc.

Recent activity